A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA.

Recent advances in efficient microRNA (miRNA) delivery techniques using brain-targeted nanoparticles offer critical information for understanding the functional role of miRNAs in vivo, and for supporting targeted gene therapy in terms of treating miRNA-associated neurological diseases. Here, we report the rabies virus glycoprotein (RVG)-labeled non-toxic SSPEI nanomaterials capable of neuron-specific miR-124a delivery to neuron in vivo. The RVG-labeled BPEI-SS (RVG-SSPEI) nanocarrier showed less toxicity in acetylcholine receptor-positive Neuro2a cells, and electrostatic interaction of RVG-SSPEI with miR-124a exhibited optimal transfection efficacy. The RVG-SSPEI polymer specifically targeted Neuro2a using cy5.5-miR-124a mixed with RVG-SSPEI. The functional action of miR-124a oligomers released from polyplexes in the cytoplasmic region was evaluated by a reporter vector containing a miR-124a -binding sequence, and showed a significantly reduced reporter signal in a dose-dependent manner. Cy5.5-miR-124a/RVG-SSPEI- injected into mice via tail veins displayed the enhanced accumulation of miR-124a in the isolated brain. Hindrance of the efficient penetration of neuronal cells by size limitation of the miR-124a/RVG-SSPEI improved with the help of mannitol through blood-brain barrier disruption. These findings indicated that the RVG peptide combined with mannitol infusion using SSPEI polymer for neuron-specific targeting in vivo is sufficient to deliver neurogenic microRNA into the brain.

[1]  Robert C. Thompson,et al.  MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. , 2008, Experimental cell research.

[2]  K. Kosik,et al.  Specific MicroRNAs Modulate Embryonic Stem Cell–Derived Neurogenesis , 2006, Stem cells.

[3]  Lena Smirnova,et al.  Regulation of miRNA expression during neural cell specification , 2005, The European journal of neuroscience.

[4]  B. Davidson,et al.  Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.

[5]  J. Rossi,et al.  Molecular medicine: Entry granted , 2007, Nature.

[6]  Saroj P. Mathupala,et al.  Delivery of small-interfering RNA (siRNA) to the brain , 2009, Expert opinion on therapeutic patents.

[7]  Jin-Zhi Du,et al.  Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. , 2010, Small.

[8]  E. Wagner,et al.  Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. , 2008, Bioconjugate chemistry.

[9]  M. Wood,et al.  Delivering RNA interference to the mammalian brain. , 2005, Current gene therapy.

[10]  V. Ambros,et al.  Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation , 2004, Genome Biology.

[11]  T. Maniatis,et al.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. , 2007, Molecular cell.

[12]  N. Boulis,et al.  Viral vector-mediated gene transfer for CNS disease , 2010, Expert opinion on biological therapy.

[13]  G. Hannon,et al.  A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons , 2007, Science.

[14]  N. Maiorano,et al.  Promotion of embryonic cortico-cerebral neuronogenesis by miR-124 , 2009, Neural Development.

[15]  S. Rapoport.  Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy , 2001, Expert opinion on investigational drugs.

[16]  F. Szoka,et al.  Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.

[17]  M. Apuzzo,et al.  Cellular and Molecular Neurosurgery: Pathways from Concept to Reality-Part II: Vector Systems and Delivery Methodologies for Gene Therapy of the Central Nervous System. , 1997, Neurosurgery.

[18]  Robert V Farese,et al.  MicroRNA-29b Regulates the Expression Level of Human Progranulin, a Secreted Glycoprotein Implicated in Frontotemporal Dementia , 2010, PloS one.

[19]  So Jin Lee,et al.  Stability and cellular uptake of polymerized siRNA (poly-siRNA)/polyethylenimine (PEI) complexes for efficient gene silencing. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[20]  D. Fischer,et al.  A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity , 1999, Pharmaceutical Research.

[21]  K. Kosik,et al.  MicroRNA-124: micromanager of neurogenesis. , 2009, Cell stem cell.

[22]  Kwangmeyung Kim,et al.  Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[23]  C. Barbato,et al.  Searching for MIND: MicroRNAs in Neurodegenerative Diseases , 2009, Journal of biomedicine & biotechnology.

[24]  B. Emery.  Transcriptional and post-transcriptional control of CNS myelination , 2010, Current Opinion in Neurobiology.

[25]  Tae-Jong Yoon,et al.  Toxicity and tissue distribution of magnetic nanoparticles in mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  I. Plante,et al.  MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1* , 2009, Journal of Biological Chemistry.

[27]  Do Won Hwang,et al.  RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[28]  C. Wahlestedt,et al.  Striatal microRNA controls cocaine intake through CREB signaling , 2010, Nature.